Suppliers / Deva Holding

Deva Holding

United Arab Emirates Updated 9 July 2026

Deva Holding is an API and finished-dose manufacturer based in United Arab Emirates. It holds 6 active US drug master files across a filed portfolio of 7 molecules. Its filings concentrate with RAMA (GE), UZPHARM (UZ) and EFDA (ET). Its GMP standing is certified by EMA, EAEU_EEC and TMDA (TZ).

6
active US DMFs
0
valid CEPs
4
registered plants
143
filings across 12 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Tekirdag, United Arab Emirates Not on file
Kocaeli, United Arab Emirates Not on file
Kartepe, Turkey Not on file
Kapakli, Turkey Not on file

What they file, and where

Molecule Regulators Docs
Amlodipine Mesilate SFDA (Saudi Arabia) 1
Dasatinib US FDA 1
Eltrombopag US FDA 1
Isoprenaline US FDA 1
Lenalidomide US FDA 1
Olaparib US FDA 1
Pomalidomide US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
RAMA (GE) 52 None
UZPHARM (UZ) 35 None
EFDA (ET) 27 None
MINSA (CR) 9 None
DIGEMAPS (DO) 7 None
US FDA 6 None
EMA None 6
EAEU_EEC None 1
TMDA (TZ) None 1

Comparing suppliers?

Choose your molecules and target markets. Deva Holding comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates